Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children.

OBJECTIVE: To describe the long-term efficacy over 5 years of regimens including combinations of abacavir, lamivudine and/or zidovudine in previously untreated children in the PENTA 5 trial. DESIGN: PENTA 5 was a 48-week randomised controlled trial comparing three dual nucleoside reverse transcripta...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Green, H, Gibb, D, Walker, A, Pillay, D, Butler, K, Candeias, F, Castelli-Gattinara, G, Compagnucci, A, Della Negra, M, de Rossi, A, Feiterna-Sperling, C, Giaquinto, C, Harper, L, Levy, J, Saidi, Y, Wintergerst, U
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	2007

Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children.

समान संसाधन